Kevin G Wolschleger MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Ambulatory Cardiology Section Chief
Join to View Full Profile
2900 Bradford St NeGrand Rapids, MI 49525
Phone+1 616-885-5000
Fax+1 616-885-5020
Dr. Wolschleger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Cardiovascular Disease, 1987 - 1990
Corewell Health (Dearborn)Residency, Internal Medicine, 1984 - 1987
American University of the Caribbean School of MedicineClass of 1984
Certifications & Licensure
MI State Medical License 1985 - 2028
WI State Medical License 1990 - 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Transient Severe Functional Mitral Valve Regurgitation: An Extremely Rare Cause of Recurrent Pulmonary Edema.Joseph Banno, Yasser Radwan, Rima Patel, Sanjay Dandamudi, Michael McNamara
JACC. Case Reports. 2023-06-21 - 1 citationsCardiac Tamponade Secondary to Hemorrhagic Pericardial Effusion: A Complication of STEMI.Marvin Kajy, Amy Rechenberg, Connor Kerndt, Kevin Wolschleger
Ochsner Journal. 2023-01-01 - 66 citationsLarge lipid-rich coronary plaques detected by near-infrared spectroscopy at non-stented sites in the target artery identify patients likely to experience future major ...Ryan D. Madder, Mustafa Husaini, Alan T. Davis, Stacie VanOosterhout, Mohsin Khan
European Heart Journal. Cardiovascular Imaging. 2016-04-01
Press Mentions
Augmented Reality Is the Future of Healthcare IndustryDecember 18th, 2019
First Patient Enrolls in STEMI DTU Randomized Controlled FDA Trial; Study Aims to Further Demonstrate Impella’s Safety and EffectivenessDecember 16th, 2019- Klinische Überprüfung Bestätigt Kosteneffizienz Von Impella Bei Hochrisiko-PCI Und Kardiogenem SchockNovember 20th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
